The aims of this Cochrane Review were to find out whether capecitabine is more useful in hormone receptor-positive or -negative breast cancers, and to see whether this di ers depending on how advanced the cancer is. We collected and analysed all relevant studies to answer this question.
What was studied in the review?Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer (Review)